Correction to: Nature https://doi.org/10.1038/s41586-021-03769-9 Published online 28 July 2021
This Article has been amended to make two clarifications. The second sentence of the Abstract paragraph, now reading “Ketamine is a racemic mixture containing equal parts of R- and S-ketamine, with the S-enantiomer having greater affinity for the NMDA receptor (Ebert, B., Mikkelsen, S., Thorkildsen, C. & Borgbjerg, F. M. Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord. Eur. J. Pharmacol. 333, 99–104 (1997)),” was changed from “Ketamine is a racemic mixture of S- and R-ketamine enantiomers, with S-ketamine isomer being the more active antidepressant (Jelen, L. A., Young, A. H. & Stone, J. M. Ketamine: a tale of two enantiomers. J. Psychopharmacol. 35, 109–123 (2021)).”
In Fig. 1f, the y-axis label now reading “Inhibition (%)” was changed from “Inhibition relative to 10 μM [3H]-MK-801 (%).” The authors note that accurate concentrations of [3H]-MK-801 are noted in the Methods, subsection “Ligand-binding assay,” particularly as “[3H]MK-801 (10 nM for GluN1–GluN2AEM receptor and rat cortex; 50 nM for GluN1–GluN2BEM receptor).” The original Article has been corrected online.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhang, Y., Ye, F., Zhang, T. et al. Author Correction: Structural basis of ketamine action on human NMDA receptors. Nature 598, E3 (2021). https://doi.org/10.1038/s41586-021-04038-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-021-04038-5
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.